|
|
Contents
|
|
|
Overview
Laboratory
Investigations
Clinical
investigations
■
Newly
diagnosed tumors
■
Recurrent
tumors
Miscellanea
|
|
|
Overview
|
|
|
|
LOCAL
TREATMENT
|
|
.
|
Kim IY.
Commentary on local therapy in men who present
with a metastatic prostate cancer from special issue senior guest
editor.
Am J Clin Exp Urol. 2019 Apr 25;7(2):61-63.
eCollection 2019.
Source
| Full
text |
Similar
articles
|
|
|
SYSTEMIC
TREATMENT
|
|
.
|
Gravis G.
Systemic treatment for metastatic prostate
cancer.
Asian J Urol. 2019 Apr;6(2):162-168. doi:
10.1016/j.ajur.2019.02.002. Epub 2019 Feb 11.
Source
| Full
text |
Similar
articles
|
|
|
Laboratory
investigations
|
|
|
|
Clinical
investigations
|
|
|
|
RADIOTHERAPY
|
|
.
|
Khullar K, Parikh RR.
The role of radiotherapy in
metastatic prostate cancer.
Am J Clin Exp Urol. 2019 Apr
25;7(2):92-97. eCollection 2019.
Source
| Full
text |
Similar
articles
|
|
|
Newly
diagnosed tumors
|
|
|
|
RADIOTHERAPY
|
|
|
|
NEWLY
DIAGNOSED, METASTATIC PROSTATE CANCER
|
|
|
Aparicio A, Thall P, Logothetis C.
Radiotherapy for
metastatic prostate cancer.
Lancet. 2019 Sep
7;394(10201):829-830. doi: 10.1016/S0140-6736(19)31783-0.
Source
.
Similar
articles
Comment
on: Parker CC, James ND, et al.,Radiotherapy to the primary tumour
for newly diagnosed, metastatic prostate cancer (STAMPEDE): a
randomised controlled phase 3 trial. Lancet. 2018 Dec
1;392(10162):2353-2366. doi: 10.1016/S0140-6736(18)32486-3. Epub
2018 Oct 21. Source
.
Similar
articles
|
|
|
|
Gouda MA.
Radiotherapy for metastatic prostate cancer.
Lancet. 2019 Sep 7;394(10201):829. doi:
10.1016/S0140-6736(19)31782-9.
Source
.
Similar
articles
Comment
on: Parker CC, James ND, et al.,Radiotherapy to the primary tumour
for newly diagnosed, metastatic prostate cancer (STAMPEDE): a
randomised controlled phase 3 trial. Lancet. 2018 Dec
1;392(10162):2353-2366. doi: 10.1016/S0140-6736(18)32486-3. Epub
2018 Oct 21. Source
.
Similar
articles
|
|
|
|
Parker CC, James ND, Brawley CD, Clarke NW, Parmar MKB.
Radiotherapy for metastatic prostate cancer-Authors'
reply.
Lancet. 2019 Sep 7;394(10201):830. doi:
10.1016/S0140-6736(19)31829-X.
Source
.
Similar
articles
Comment
on: (1) Aparicio A et al.,Radiotherapy for metastatic prostate
cancer. Lancet. 2019 Sep 7;394(10201):829-830. doi:
10.1016/S0140-6736(19)31783-0.
Source
.
Similar
articles (2)
Gouda
MA.,Radiotherapy for metastatic prostate cancer. Lancet. 2019 Sep
7;394(10201):829. doi: 10.1016/S0140-6736(19)31782-9.
Source
.
Similar
articles
|
|
|
|
Parker CC, James ND, et al.
Radiotherapy to the primary
tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE):
a randomised controlled phase 3 trial.
Lancet. 2018 Dec
1;392(10162):2353-2366. doi: 10.1016/S0140-6736(18)32486-3. Epub
2018 Oct 21.
Source
.
Similar
articles
|
|
|
Recurrent
tumors
|
|
|
|
Miscellanea
|
|
|
|
|
|
|
|
|
|
